搜索临床试验以:Potential drug-drug interaction
总计4851个结果
-
Achieve Life SciencesTeva Branded Pharmaceutical Products R&D, Inc.完全的
-
Tibotec Pharmaceuticals, Ireland完全的
-
Tomsk National Research Medical Center of the Russian...招聘中
-
Washington State UniversityNational Center for Complementary and Integrative Health (NCCIH)招聘中
-
Turning Point Therapeutics, Inc.招聘中
-
Tomsk National Research Medical Center of the Russian...招聘中
-
University of Ioannina招聘中
-
National Cancer Institute (NCI)主动,不招人造血和淋巴细胞肿瘤 | 晚期淋巴瘤 | 晚期恶性实体瘤 | 难治性淋巴瘤 | 难治性恶性实体瘤 | 难治性多发性骨髓瘤美国
-
University of California, San FranciscoFood and Drug Administration (FDA)主动,不招人
-
DICE Therapeutics, Inc., a wholly owned subsidiary...完全的
-
Medicines for Malaria VentureShin Poong Pharmaceuticals完全的
-
Washington State UniversityNational Center for Complementary and Integrative Health (NCCIH); Office of Dietary Supplements...主动,不招人
-
Radboud University Medical CenterGilead Sciences完全的
-
Pop Test Oncology LLCBaylor College of Medicine; Michael E. DeBakey VA Medical Center; Congressionally Directed Medical... 和其他合作者完全的
-
MODAG GmbHTeva Pharmaceutical Industries, Ltd.; Quotient Sciences; Aptuit完全的
-
Pfizer完全的系统性间变性大细胞淋巴瘤 | 非小细胞肺癌 ALK 阳性 | 非小细胞肺癌 c-Met 依赖 | 非小细胞肺癌 ROS 标志物阳性 | 除白血病外的晚期恶性肿瘤美国, 大韩民国, 澳大利亚, 日本
-
Maastricht UniversityEuropean Commission完全的